Pierre Socha

Pierre Socha is a seasoned investor and partner at Amadeus Capital Partners since 2012, specializing in industry-defining technologies across various sectors including Healthtech, Quantum, and Cybersecurity, managing over $1 billion in assets with more than 200 investments. In addition to investment activities, Pierre serves on the boards of several innovative companies such as Constructive Bio, V7, Quibim, Ori Biotech, OrganOx, Inotec AMD, Charco, PhoreMost Ltd, and Doctify, focusing on advancing synthetic reprogramming, AI-driven computer vision, companion diagnostics, and cell and gene therapy delivery. Pierre's educational background includes executive programs from prestigious institutions such as MIT, Harvard Business School, and Stanford University, along with a Master's in Environmental Economics and a Bachelor's in Finance & Econometrics.